Ends: 10-Aug-26 | Co: CSQR
Csquare (NYSE) | North American digital infrastructure provider that owns and operates carrier-neutral data centers offering colocation and interconnection services across the U.S., Canada, and the U.K. | Opened: 16-Jul-26, $20.90 | Priced: $21.00 | Underwriters: Lead: Morgan Stanley and TD Securities |
Ends: 10-Aug-26 | Co: STDN
Standard Nuclear (NYSE) | Advanced nuclear technology company focused on producing TRISO fuel and radioisotope power systems for next-generation energy, defense, and space applications | Opened: 16-Jul-26, $13.50 | Priced: $15.00 | Underwriters: Lead: BofA Securities and Goldman Sachs & Co. LLC |
Ends: 18-Aug-26 | Co: SCTX
Scribe Therapeutics (Nasdaq) | Clinical-stage biotechnology company developing CRISPR-based genetic medicines for cardiovascular and metabolic diseases | Opened: 24-Jul-26, $25.00 | Priced: $15.0 | Underwriters: Lead: Leerink Partners, Goldman Sachs & Co. LLC, Guggenheim Securities, and Wells Fargo Securities |
Ends: 24-Aug-26 | Co: IOND
Ionic Digital (Nasdaq) | Digital infrastructure company focused on bitcoin mining and AI/HPC data center infrastructure | Opened: 28-Jul-26, $50.00 | Priced: NA | Underwriters: Lead: Jefferies LLC, or Jefferies, and BTIG, LLC |
Ends: 24-Aug-26 | Co: JMKE
Jersey Mike's (NYSE) | Fast-casual sandwich chain and franchisor with more than 3,300 locations across the U.S. and Canada, known for its fresh-sliced subs and rapid growth | Opened: 30-Jul-26, $21.00 | Priced: $23.00 | Underwriters: Lead: Morgan Stanley, Jefferies, and J.P. Morgan |
Ends: 24-Aug-26 | Co: REF
Reformation (NYSE) | Sustainable women's fashion brand with a global retail and e-commerce presence | Opened: 30-Jul-26, $15.00 | Priced: $15.00 | Underwriters: Lead: J.P. Morgan and Morgan Stanley |
Ends: 25-Aug-26 | Co: APMD
Apnimed (Nasdaq) | Clinical-stage pharmaceutical firm developing oral therapies for obstructive sleep apnea and other sleep-related breathing disorders | Opened: 31-Jul-26, $22.00 | Priced: $16.00 | Underwriters: Lead: BofA Securities, Inc., Evercore Group L.L.C. and Cantor Fitzgerald & Co. |
Ends: 31-Aug-26 | Co: ATTO
Attovia Therapeutics (Nasdaq) | Clinical-stage biopharmaceutical company developing next-generation biologics for immune-mediated diseases, led by an experimental therapy targeting chronic itch and inflammatory conditions | Opened: 05-Aug-26, $21.00 | Priced: $17.00 | Underwriters: Lead: Morgan Stanley, Leerink Partners, Citigroup, RBC Capital Markets, LifeSci Capital |
Ends: 31-Aug-26 | Co: BRVE
Braveheart Bio (Nasdaq) | Clinical-stage biopharmaceutical company developing a next-generation oral therapy for hypertrophic cardiomyopathy | Opened: 06-Aug-26, $30.20 | Priced: $18.00 | Underwriters: Lead: Goldman Sachs & Co. LLC, Jefferies, TD Cowen, Stifel, Cantor |
Ends: 31-Aug-26 | Co: RCBC
River City Bank (Nasdaq) | California commercial bank focused primarily on commercial real estate lending | Opened: 06-Aug-26, $45.00 | Priced: $45.00 | Underwriters: Lead: Raymond James, Keefe Bruyette Woods |
Ends: 01-Sep-26 | Co: BLSM
BlossomHill Therapeutics (Nasdaq) | Clinical-stage biopharmaceutical developing next-generation small molecule cancer therapies designed to overcome limitations of existing treatments | Opened: 07-Aug-26, $15.75 | Priced: $16.00 | Underwriters: Lead: J.P. Morgan, Leerink Partners, Guggenheim Securities, LifeSci Capital, H.C. Wainwright & Co. |
Ends: 01-Sep-26 | Co: LTGO
Latigo Biotherapeutics (Nasdaq) | Clinical-stage biopharmaceutica developing non-opioid pain medicines designed to provide fast-acting, non-addictive pain relief | Opened: 07-Aug-26, $21.00 | Priced: $18.00 | Underwriters: Lead: Goldman Sachs & Co. LLC, Jefferies, Leerink Partners, Guggenheim Securities |
Ends: 01-Sep-26 | Co: TP
Ticketplus Ltd. (Nasdaq) | Live events technology company providing smart ticketing and SaaS infrastructure for event discovery, sales, access control, and analytics across Latin America | Opened: 07-Aug-26, $7.00 | Priced: $8.00 | Underwriters: Lead: Roth Capital Partners, Bancroft Capital, LLC, MDB Capital |
Ends: 07-Sep-26 | Co: FOIL
Londian Wason New Energy Tech (NYSE) | Global leader in electrolytic copper foil, supplying battery and electronics manufacturers for EVs, energy storage, and advanced technology applications | Opened: 12-Aug-26, $26.00 | Priced: $22.00 | Underwriters: Lead: Cantor, Huatai Securities, CMB International, US Tiger Securities |